Advertisement
Screener

ARCTURUS THERAPEUTICS HOLDINGS INC. (ARCT) Graph

ARCT Revenue Flow

Filed revenue amounts for 2026-04-01 to 2026-06-30. Coverage is partial. Unconnected amounts are separate disclosures; they must not be added together.

  • 2026-06-30: Revenue $2.96M; Research and development $17.52M; Operating expenses $28.50M; Income tax $0.00.
  • 2026-03-31: Revenue $2.06M; Research and development $21.53M; Operating expenses $30.99M; Income tax (m).
  • 2025-12-31: Revenue $7.20M*; Research and development $24.48M*; Operating expenses $38.50M*; Income tax (m).
  • 2025-09-30: Revenue $17.15M; Research and development $23.27M; Operating expenses $33.66M; Income tax (m).

Product or service

Separate filed amounts; connecting flows are not established. Components and totals may overlap.

ARCT revenue flowFiled amounts. Only explicit calculation relationships connect amounts; dimensional membership alone does not establish an additive flow.Collaboration Revenue$880.00KGrant$2.08MRevenue$2.96MOperating expenses$28.50MOperating income-$25.54MOther income, net-$59.00KResearch & development$17.52MPre-tax income-$23.78MIncome tax$0.00Net income-$23.78M

Finer product or service dollar figures and nonoverlapping groupings are shown only where supported by the retained filing evidence. Growth percentages are never converted to revenue dollars.

Historical revenue and expense breakdown

Revenue and expense 3 month

Period endRevenueResearch and developmentOperating expensesIncome taxNet income
2026-06-30$2.96M$17.52M$28.50M$0.00-$23.79M
2026-03-31$2.06M$21.53M$30.99M(m)-$26.96M
2025-12-31$7.20M*$24.48M*$38.50M*(m)-$29.08M*
2025-09-30$17.15M$23.27M$33.66M(m)-$13.45M
2025-06-30$28.30M$29.58M$39.92M$4.00K-$9.18M
2025-03-31$29.38M$34.89M$46.21M$0.00-$14.08M
2024-09-30$41.67M$39.13M$52.41M-$217.00K-$6.90M
2024-06-30$49.86M$58.67M$70.98M-$150.00K-$17.22M
2024-03-31$38.01M$53.57M$68.42M$368.00K-$26.82M
2023-09-30$45.14M$51.08M$64.45M$893.00K-$16.22M
2023-06-30$10.52M$52.67M$65.89M$577.00K-$52.55M
2023-03-31$80.28M$51.77M$65.53M$103.00K$50.75M
2022-09-30$13.37M$37.69M$50.18M$0.00-$35.27M
2022-06-30$27.09M$38.19M$49.18M$0.00-$21.56M
2022-03-31$5.24M$44.89M$55.62M$100.00K-$51.17M
2021-12-31$5.79M$32.63M(m)(m)-$38.66M
2021-09-30$2.44M$45.40M$56.26M$0.00-$54.08M
2021-06-30$2.00M$45.68M$55.72M$0.00-$54.58M
2021-03-31$2.13M$50.05M$59.79M$0.00-$56.35M
2020-12-31$2.24M$24.29M(m)(m)-$31.10M
2020-09-30$2.33M$17.70M$23.27M$0.00-$21.00M
2020-06-30$2.32M$7.94M$12.36M$0.00-$10.26M
2020-03-31$2.65M$7.92M$12.11M$0.00-$9.78M
2019-12-31$2.97M$11.99M(m)(m)-$10.99M
2019-09-30$3.32M$7.05M$10.93M(m)-$7.43M
2019-06-30$10.15M$7.27M$10.72M(m)-$685.00K
2019-03-31$4.35M$7.32M$10.86M(m)-$6.88M
2018-09-30$3.42M$3.97M$7.78M(m)-$4.25M
2018-06-30$2.39M$4.22M$12.46M(m)-$9.95M

Revenue and expense 6 month

Period endRevenueResearch and developmentOperating expensesIncome taxNet income
2026-06-30$5.02M$39.04M$59.50M$0.00-$50.75M
2025-06-30$57.68M$64.47M$86.13M$4.00K-$23.26M
2024-06-30$87.87M$112.24M$139.41M$218.00K-$44.03M
2023-06-30$90.80M$104.44M$131.42M$680.00K-$1.80M
2022-06-30$32.34M$83.08M$104.81M$0.00-$72.73M
2021-06-30$4.13M$95.73M$115.51M$0.00-$110.93M
2020-06-30$4.97M$15.86M$24.47M$0.00-$20.04M
2019-06-30$14.50M$14.59M$21.58M(m)-$7.57M
2018-06-30$4.75M$8.17M$21.50M(m)-$16.52M

Revenue and expense 9 month

Period endRevenueResearch and developmentOperating expensesIncome taxNet income
2025-09-30$74.83M$87.74M$119.79M$4.00K-$36.70M
2024-09-30$129.54M$151.38M$191.82M$0.00-$50.94M
2023-09-30$135.94M$155.51M$195.88M$1.57M-$18.02M
2022-09-30$45.71M$120.77M$154.98M$0.00-$108.00M
2021-09-30$6.57M$141.13M$171.77M$0.00-$165.01M
2020-09-30$7.30M$33.56M$47.74M$0.00-$41.04M
2019-09-30$17.82M$21.65M$32.52M(m)-$15.00M
2018-09-30$8.18M$12.13M$29.28M(m)-$20.77M

Revenue and expense 12 month

Period endRevenueResearch and developmentOperating expensesIncome taxNet income
2025-12-31$82.03M$112.21M$158.29M(m)-$65.78M
2024-12-31$152.31M$195.16M$247.98M-$4.00K-$80.94M
2023-12-31$166.80M$192.13M$245.00M$1.83M-$29.73M
2022-12-31$206.00M$147.75M$193.82M$1.29M$9.35M
2021-12-31$12.36M$173.76M$215.21M(m)-$203.67M
2020-12-31$9.54M$57.85M$81.06M(m)-$72.15M
2019-12-31$20.79M$33.64M$46.30M(m)-$25.99M
2018-12-31$15.75M$16.98M$37.56M(m)-$21.79M

Similar stocks

Stock NameCountryMarket CapPE Ratio
GALECTIN THERAPEUTICS INC (GALT)United States$0.399B-11.06
Opus Genetics, Inc. (IRD)United States$0.406B-3.16
RELMADA THERAPEUTICS, INC. (RLMD)United States$0.406B-11.92
Turn Therapeutics Inc. (TTRX)United States$0.397B-25.68
ARS Pharmaceuticals, Inc. (SPRY)United States$0.414B-3.70
Atea Pharmaceuticals, Inc. (AVIR)United States$0.414B-2.26
Rezolute, Inc. (RZLT)United States$0.382B-6.45
DiaMedica Therapeutics Inc. (DMAC)United States$0.423B-10.11
PROTHENA CORP PUBLIC LTD CO (PRTA)Ireland$0.428B-11.53
CYPHERPUNK TECHNOLOGIES INC. (CYPH)United States$0.438B-75.63